Industries

Life Sciences Litigation

Overview

CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.

CRA has a reputation for delivering rigorous analysis and expert testimony. Economic expertise is complemented by experience assisting life sciences companies with business and policy issues. This combination allows CRA to provide effective expert testimony and support.

01

Analysis of an alleged breach of a Contingent Value Rights (CVR) agreement involving CAR-T and small-molecule products

Plaintiffs alleged that the defendant failed to exert Diligent Efforts to secure FDA approval of a set of CAR-T and small-molecule products, which terminated a...
View engagement
02

Damages due to misappropriation of trade secrets and confidential information by multiple parties

CRA calculated actual loss, reasonable royalty damages, and unjust enrichment due to the plaintiff. Dr. Gregory K Bell provided opening and reply reports and...
View engagement
03

Lost profit damages due to manufacturer for alleged counterfeit sales

CRA calculated the lost profits due to the manufacturer for the counterfeit drug products sold and distributed by the defendants. CRA’s analysis assisted...
View engagement